P

Inventor

TAIT BRADLEY

US21 patents
⚠️ This page may combine multiple inventors who share the name “TAIT BRADLEY”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

PROTEOSTASIS THERAPEUTICS INC

14 patents
US10392378B2Aug 27, 2019

Derivatives of 5-phenyl- or 5-heteroarylathiazol-2-carboxylic amide useful for the treatment of inter alia cystic fibrosis

PROTEOSTASIS THERAPEUTICS INC7 citations84
US10392372B2Aug 27, 2019

Compounds, compositions, and methods for increasing CFTR activity

PROTEOSTASIS THERAPEUTICS INC6 citations84
US10174014B2Jan 8, 2019

Compounds, compositions, and methods for increasing CFTR activity

PROTEOSTASIS THERAPEUTICS INC9 citations84
US10017503B2Jul 10, 2018

Compounds, compositions, and methods for increasing CFTR activity

PROTEOSTASIS THERAPEUTICS INC11 citations84
US9790219B2Oct 17, 2017

Compounds, compositions, and methods for increasing CFTR activity

PROTEOSTASIS THERAPEUTICS INC16 citations84
US9745292B2Aug 29, 2017

Compounds, compositions, and methods for increasing CFTR activity

PROTEOSTASIS THERAPEUTICS INC14 citations84
US10344023B2Jul 9, 2019

Derivatives of 3-heteroarylisoxazol-5-carboxylic amide useful for the treatment of inter alia cystic fibrosis

PROTEOSTASIS THERAPEUTICS INC6 citations73
US11242361B2Feb 8, 2022

Proteasome activity enhancing compounds

PROTEOSTASIS THERAPEUTICS INC2 citations71
US11098035B2Aug 24, 2021

Compounds, compositions, and methods for increasing CFTR activity

PROTEOSTASIS THERAPEUTICS INC0 citations62
US10738011B2Aug 11, 2020

Derivatives of 5-(hetero)arylpyrazol-3-carboxylic amide or 1-(hetero)aryltriazol-4-carboxylic amide useful for the treatment of inter alia cystic fibrosis

PROTEOSTASIS THERAPEUTICS INC1 citations62
US10738040B2Aug 11, 2020

Compounds, compositions, and methods for increasing CFTR activity

PROTEOSTASIS THERAPEUTICS INC1 citations62
US11746098B2Sep 5, 2023

Proteasome activity enhancing compounds

PROTEOSTASIS THERAPEUTICS INC1 citations60
US10532996B2Jan 14, 2020

Proteostasis regulators

PROTEOSTASIS THERAPEUTICS INC0 citations50
US9399647B2Jul 26, 2016

Proteasome activity modulating compounds

PROTEOSTASIS THERAPEUTICS INC0 citations40

SCHERING CORP

2 patents

KINETA INC

2 patents

FREQUENCY THERAPEUTICS INC

2 patents

FOLEY MEGAN

1 patent